First Light Asset Management, LLC Aldeyra Therapeutics, Inc. Transaction History

First Light Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.5 - $9.63 $10.4 Million - $28.8 Million	-2,985,712 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$7.94 - $11.31 $3.86 Million - $5.49 Million	-485,747 Reduced 13.99%	2,985,712 $26.2 Million
Q2 2021 Aug 13, 2021	BUY	$10.44 - $14.85 $8.85 Million - $12.6 Million	847,458 Added 32.3%	3,471,459 $39.3 Million
Q1 2021 May 17, 2021	BUY	$6.53 - $14.42 $17.1 Million - $37.8 Million	2,624,001 New	2,624,001 $31.2 Million

106

35.1M

153K

83.9K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $321M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.